DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

DRDO issues directions on usage of anti-Covid drug

New Delhi: In a bid to tackle mis-information on social media regarding the Covid therapy drug ‘2DG’, the Defence Research and Development Organisation (DRDO) on Tuesday tweeted the usage of the drug and again advised people on who all can...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

New Delhi: In a bid to tackle mis-information on social media regarding the Covid therapy drug ‘2DG’, the Defence Research and Development Organisation (DRDO) on Tuesday tweeted the usage of the drug and again advised people on who all can be its users. “Doctors can prescribe the drug as early as possible for moderate to severe Covid patients for maximum duration of 10 days. The impact of the drug on patients with uncontrolled diabetes, severe cardiac problem, severe hepatic and renal impairment has not been studied yet, hence caution should be exercised,” the DRDO said in tweet. TNS

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper